ATRX and neoplasm: One patient’s tumor with ALT phenotype as the sole telomere maintenance mechanism had no H3-3A mutations but harbored both ATRX and IDH (R132C) mutations, suggesting that IDH alterations, in cooperation with ATRX loss, may alternatively drive the ALT pathway, as previously described.41